Dreams and Bereavement (DreamDeath)

February 27, 2024 updated by: Hospices Civils de Lyon

Investigation of the Links Between Waking-life and Dream Content in the Case of the Death of a Close Relative

The aim of the study is to investigate a possible role of dreaming in emotion regulation testing whether dreaming of a close relative recently deceased is correlated with a positive evolution of the bereavement process

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Bron, France, 69500
        • Hospices Civils de Lyon Hôpital le Vinatier/Inserm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age > or = 18 years old
  • the death of a close relative in the last 3 months

Exclusion Criteria:

- history of psychiatric and neurologic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy subjects
Behavioral: web form
The scale assessing the bereavement process is the one reported in Teissier 2010

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 1
Day 1
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 90
Day 90
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 180
Day 180
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 270
Day 270
Frequency of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 360
Day 360

Secondary Outcome Measures

Outcome Measure
Time Frame
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 1
Day 1
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 90
Day 90
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 180
Day 180
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 270
Day 270
Content of dreams related to the deceased will be correlated to the score at the scale assessing the bereavement process
Time Frame: Day 360
Day 360

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: Alain Nicolas, MD, Hôpital le Vinatier/Inserm

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2018

Primary Completion (Actual)

April 9, 2023

Study Completion (Actual)

April 9, 2023

Study Registration Dates

First Submitted

April 5, 2017

First Submitted That Met QC Criteria

April 5, 2017

First Posted (Actual)

April 11, 2017

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 69HCL17_0075
  • 2017-A00640-53 (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on web form

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe